Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

3 Stocks Defying the Dow’s Drop: Bank of America Corp (BAC), Pfizer Inc. (PFE) and More

Despite the lack of critical economic news today, stock markets are falling to start the week. The Dow Jones Industrial Average is down 0.15% as of 3:15 p.m. EST, and the S&P 500 has fallen barely more than a point. But there are a few stocks moving significantly higher, even as markets fall.

Bank of America Corp (NYSE:BAC) has led financials upward today by climbing 10.9%. There wasn’t anything specific driving Bank of America today, but investors are placing their bets now for what’s to come. Barclays reports earnings tomorrow and is expected to cut $3 billion in costs, as well as 2,000 employees. This would create more opportunity for Bank of America going forward. We’re also in the midst of a two-day meeting of eurozone finance ministers and a G-20 finance minister meeting later this week. For now, investors are baking bullish bets ahead of both.

Bank of America Corp (NYSE:BAC)Microsoft Corporation (NASDAQ:MSFT) is up 0.9% after a smashing debut of the Surface Pro, which sold out in short order. The upgraded tablet went on sale on Saturday, and it was a huge success for Microsoft, albeit a crushing disappointment for those who wanted one but missed out. The warm reception is a bit shocking, considering the apathy consumers and investors showed the original Surface tablet. Maybe Microsoft was caught off guard by higher demand — something it isn’t used to in the device business but which investors could get used to.

Pfizer Inc. (NYSE:PFE) is up 1% today after dropping 2.7% last week, when the company announced a plan to cut $1 billion from its budget by getting out of a clinical-research facility in Singapore. That caused a sell-off last week that may have been overdone. The money isn’t being invested in future products, but it can be used to pay investors in the near term. It does underscore the challenge for drugmakers going forward. Returns are getting smaller on billion-dollar drug bets, so there’s less incentive to make them at all.

The article 3 Stocks Defying the Dow’s Drop originally appeared on and is written by Travis Hoium.

Fool contributor Travis Hoium owns shares of Microsoft. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings, or follow his CAPS picks at TMFFlushDraw. The Motley Fool owns shares of Bank of America and Microsoft.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!